Skip to main content
. 2015 Mar 19;10(3):e0120794. doi: 10.1371/journal.pone.0120794

Fig 3. Serum INF-related miRNAs as prognostic biomarkers for treatment outcome in CHC.

Fig 3

ROC curve analysis of serum miR-34a (a), miR-130a (b), miR-192 (c), miR-195 (d), and miR-296 (e) as prognostic biomarkers discriminating SVR (n = 69) from NR patients (n = 37).